Yujun Shi

20PUBLICATIONS
53CO-AUTHORS
MechanobiologyCancer therapy (excl. chemotherapy and radiation therapy)Biological adaptationPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Feb 18, 2026
Arginase 1 promotes hepatic lipogenesis by regulating ERK2/PPARγ signaling in a non-canonical manner.

Mingyang Shao, Xiaoyue Cao, Yuwei Chen

|Jan 21, 2026
Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Xiaoyun Zhang, Haozheng Cai, Wei Peng

|Nov 29, 2025
Avian GCGR-mediated continuous fat utilization offers perspectives for obesity treatment.

Chang Zhang, Xue Wang, Chenxi Feng

|Nov 06, 2025
KAT2A-driven succinylation of SRSF11 enforces spliceosome-mediated RAD52 splicing to promote homologous recombination and radioresistance in hepatocellular carcinoma.

Jun Wu, Jingsheng Yuan, Zijian Liu

|May 26, 2025
Acetylation profiling by Iseq-Kac reveals insights into HSC aging and lineage decision.

Yanqiu Gong, Huiwen Zhan, Ni Wei

|May 03, 2025
Loss of NUMB promotes hepatomegaly and hepatocellular carcinoma through the AKT/glycogen/hippo signaling.

Yuke Shu, Qing Tao, Qing Xu

Pageof 4

Frequent Collaborators

3 joint publications

Qing Xu

2 joint publications

Jiayin Yang

2 joint publications

Heng Xu

2 joint publications

Yong Peng